Assessing QTc Interval Changes After Droperidol in Emergency Patients
Official title: Low-Dose Droperidol and Its Association with QTc Interval Changes in Emergency Department Patients
Run by CHRISTUS Health · NCT06726811 · Data updated 2026-11-12
This study is testing if giving low-dose Droperidol to emergency patients affects their heart rhythm by looking at changes in the QTc interval before and after treatment.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | CHRISTUS Health Academic / other |
| Locations | 1 site (Corpus Christi, Texas) |
| Status | Recruiting |
| Started | October 17, 2024 |
| Main results expected | September 30, 2025 |
| Study ends | September 30, 2026 |
| Registry record updated | December 17, 2024 |
| Trial ID | NCT06726811 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adult emergency department patients aged 18 and older who are in a cardiovascular-monitored bed and have Droperidol ordered.
✕Probably not a fit
Patients who are unable to provide consent or have already received Droperidol before the ECG will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to evaluate the effects of low-dose Droperidol on QTc interval changes in patients treated in the emergency department. Adult patients aged 18 and older, who are in a cardiac-monitored bed and have an ECG performed, will receive 2.5 mg of IV Droperidol. ECGs will be recorded before and after the administration of Droperidol to assess any significant changes in the QTc interval. The primary outcome is to determine the percentage of patients experiencing a clinically significant increase in QTc after treatment.
Why it matters
Potential benefit: If successful, this study could provide insights into the safety of Droperidol regarding its effects on heart rhythm in emergency department patients.
How similar studies have gone: While there have been studies on Droperidol and QTc intervals, this specific observational approach to assess low-dose effects in an emergency setting is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * ED patients ages 18 years or older in a cardiovascular-monitored bed who have both an ECG and a 2.5 mg dose of IV droperidol ordered by their treating physician will be eligible for inclusion. Exclusion Criteria: * Refusal to provide consent. * Administration of droperidol before the first ECG is performed. * Inability to complete the consent form and questionnaire due to clinical instability, severe pain, or disorientation as determined by a study physician.
Where it's running
-
CHRISTUS Spohn Hospital Corpus Christi-Shoreline
Corpus Christi, Texas, United States Recruiting
Study contacts
- Study coordinator: Aaron K Bartoe, DO, MS
- Email: aaronkbartoe@gmail.com
- Phone: (863) 532-8408
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Improving Sleep for Older Adults in the Emergency Department
This project tests whether wearing a Fitbit overnight can help understand and improve sleep for adults 70 and older in the emergency department who are likely to be admitted.
-
Digital Triage Prompts to Speed ED Throughput
This study tests whether adding digital checkboxes at triage helps nurses choose initial management steps to move patients through the ED faster.
-
Cardiac point-of-care ultrasound training pathway for emergency advanced practice providers
This project will test a simulation-based and just-in-time training program to teach emergency department nurse practitioners and physician assistants to perform focused cardiac POCUS.
-
Monitoring heart rhythm changes in children taking psychotropic medications
This study looks at how often heart rhythm changes happen in kids and teens taking mental health medications to see when they should have heart checks to keep them safe.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.